The Smartinhaler™: Addressing the problem of medication adherence with an innovative digital health solution (#2051)

Creation
Draft
Initial
Detailed
Accepted
Adoption
Idea Description
Supplementary Information
Innovation 'Elevator Pitch':
Smartinhaler™ is an innovative electronic medication sensor that improves suboptimal medication use in patients with chronic respiratory diseases, including asthma and COPD. Our current focus is in asthma.
Overview of Innovation:
Poor medication adherence is one of the leading issues in the management of asthma and is thought to account for 34% of all asthma deaths (Royal College of Physicians, 2014) and treatment adherence to inhaled corticosteroids could reduce hospitalisation by 60% (Williams et al., 2004).
Smartinhaler™ (by Adherium Ltd) is a digital health solution to improve medication adherence in patients with chronic respiratory diseases. This is how it works: Smartinhaler™ clips onto an existing prescription inhaler. Once installed, the Smartinhaler™ device (1) periodically remind patients to take their medication, (2) records the date and time of inhaler use (independent of patient action), (3) transmits patient usage data to a mobile device and into Adherium’s cloud-based servers for patients and/or clinicians to review, and (4) provides warnings when the data indicate the patient’s disease may be escaping control.
The benefits of the Smartinhaler™ have been validated by independent clinical research. Four randomised controlled trials have shown consistent improvement in asthma medication adherence, ranging from 144% to 180% in children (Chan et al., 2015; Morton et al. 201X) and 33.3% to 58.7% in adults (Charles et al. 2007; Foster et al., 2014). Subsequently, the three studies measuring clinical outcome have demonstrated improved patient health as indicated by a reduction in oral corticosteroid use, reliever medication use, emergency room visits, lost school days and asthma morbidity score (Foster et al., 2014; Chan et al., 2015; Morton et al., 201X).
Audiovisual reminders markedly improve adherence to inhaled corticosteroids and thus increase health outcomes, whilst tracking reliever use may allow early detection of severe exacerbations (Patel et al., 2015). Furthermore, the objective nature of electronic adherence data enables an open and honest discussion about adherence and the barriers encountered by the patient. In turn, through HCP (or parental) intervention, this results in practical solutions to better manage asthma and or COPD.
The Smartinhaler™ platform was designed with patients in mind. In the development of the Smartinhaler, we’ve consulted patients and medical professionals to produce a user-centred system that facilitates good medical practice as well as empowering the patient.
For a list of references please visit our website: http://www.smartinhaler.com/outcomes/
 
 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
Comments2
Similar Content3

Comments

Sounds as if matched to individual inhaler user's needs; and has potential to optimise adherence and thus minimise avoidable deterioration of long term condition-in this case asthma- happier patient/carer and happier NHS finance chiefs!
This is a great innovation that can really empower asthma patients, anything that can help self management / education and medication aherence will not only improve their quality of life but will also lead to reductions in emergency hospital visits / pressure on NHS services - thereby saving money for the NHS. 
5.5
2
Votes
-99999

Created by

Share and Follow